| Characteristic | Detail |
|---|---|
| Active Ingredients | Vardenafil 20mg, Dapoxetine 60mg |
| Formulation Type | Tablet |
| Usage | Erectile Dysfunction and Premature Ejaculation |
| Administration | Oral |
| Availability | Prescription Only |
| Learn More | |
Generic Names and Composition
Extra Super Levitra is a combination therapy. It includes Vardenafil 20mg and Dapoxetine 60mg. These components act together to address erectile dysfunction and premature ejaculation. Vardenafil is a PDE5 inhibitor. Dapoxetine is a selective serotonin reuptake inhibitor. Both drugs have unique roles in improving sexual performance. Patients seek this combined therapy for its dual action benefits.
Generic variations are available. They match the efficacy of branded options. Generic drugs ensure affordability while maintaining therapeutic effects. Extra Super Levitra stands out due to its dual pharmacological action. It offers a solution for dual sexual health challenges. This combination therapy represents a significant advancement in treating male sexual health disorders.
Mechanism of Action
Vardenafil 20mg functions by enhancing blood flow. It inhibits the enzyme phosphodiesterase-5. This action boosts nitric oxide levels, facilitating erection. By contrast, Dapoxetine 60mg modulates neurotransmitter levels in the brain. It delays ejaculation, extending sexual activity duration. Together, they create a comprehensive treatment.
In tandem, these mechanisms target physical and psychological facets of sexual performance. Improved blood flow and delayed ejaculation improve the sexual experience. This multifaceted approach benefits men dealing with complex sexual dysfunction issues. Patients report enhanced satisfaction and confidence.
FDA-Approved Indications
Extra Super Levitra has not received FDA approval. However, it is prescribed for erectile dysfunction and premature ejaculation. Each component is FDA-approved individually. Physicians often prescribe this combination based on clinical judgment.
Professional advice is essential. The combination is not suitable for everyone. Patients with heart issues or who take nitrate drugs should consult healthcare providers. Individual health status dictates prescription suitability.
Pregnancy and Breastfeeding Considerations
Extra Super Levitra is intended for male use. Its relevance to pregnancy and breastfeeding is negligible. Women should not use this medication. Research on effects during pregnancy or breastfeeding is limited.
Men with pregnant partners should seek medical advice. Safety profiles for expectant partners are not established. Health providers offer personalized guidance for such scenarios. Couples should discuss concerns with a healthcare professional.
Toxicity and Safety Profile
Safety is a concern with any medication. Overdose risks exist with Extra Super Levitra. Symptoms include dizziness, fainting, or chest pain. Immediate medical attention is necessary if overdose occurs.
Potential interactions are notable. It interacts with nitrate medications and some heart drugs. Comprehensive medical history disclosure to physicians is critical. Monitoring for side effects like vision changes or prolonged erections is vital.
Prescription Status and Accessibility
Extra Super Levitra is not available without a prescription. It is essential to consult a healthcare professional before use. Physicians assess suitability based on individual health profiles.
Reliable pharmacies offer this medication. Beware of non-prescription sales online. Authenticity and safety cannot be guaranteed from unauthorized sources. Trustworthy healthcare guidance ensures safe and effective use.
| Parameter | Details |
|---|---|
| Metabolism | Hepatic (CYP3A4) |
| Excretion | Renal and Fecal |
Information taken from:
- https://miservis.es/infeccion-capilaria-capilariasis-y-su-impacto/
- https://dev.vivashop.ro/rolul-ursodiol-in-managementul-calculilor-biliari/
- https://sunydecor.com/radiostol-mot-cai-nhin-vao-cac-phuong-phap-dieu-tri-moi-noi/
- https://at.7bestbonus.com/2024/07/18/denosumab-injection-clinical-efficacy-and-safety-analysis/
- https://movimientoheroes.com/2024/08/01/sindrome-de-prader-willi-nuevas-terapias/
- https://baileyheard.com/hemophilia-emerging-treatment-perspectives/
- http://www.kgv-rote-muehle.de/2023/12/04/utforsker-metoclopramide-odts-rolle-i-staphylococcus-aureus-treatmen/
- https://reidomarketingdg.com.br/2024/04/10/surtos-no-tratamento-da-dor-a-ascensao-do-picendadol/
- https://yirmibirmart.com/utforska-lidokain-och-tetrakain-vid-behandling-av-extrem-kyla-hypotermi/
- https://prosportcolombia.com/2024/03/30/sindrome-de-pierre-robin-perspectivas-clinicas/